共 50 条
- [11] Cost-Effectiveness Analysis of Camrelizumab Immunotherapy versus Docetaxel or Irinotecan Chemotherapy as Second-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 8219 - 8230
- [14] Cost-effectiveness analysis of sintilimab plus chemotherapy for advanced or metastatic esophageal squamous cell carcinoma FRONTIERS IN ONCOLOGY, 2022, 12
- [17] Cost-effectiveness analysis of tislelizumab in combination with chemotherapy for the first-line treatment of patients with metastatic or recurrent nasopharyngeal carcinoma in China HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (01): : 5 - 14
- [20] Cost-effectiveness of transoral robotic surgery versus (chemo) radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysis HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (04): : 589 - 600